Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010.

Ho CM, Ho MW, Liu YC, Toh HS, Lee YL, Liu YM, Huang CC, Lu PL, Liu CE, Chen YH, Ko WC, Tang HJ, Yu KW, Chen YS, Chuang YC, Wang JH, Hsueh PR.

Int J Antimicrob Agents. 2012 Jun;40 Suppl:S24-8. doi: 10.1016/S0924-8579(12)70006-7.

PMID:
22749055
2.

Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.

Lee YL, Chen YS, Toh HS, Huang CC, Liu YM, Ho CM, Lu PL, Ko WC, Chen YH, Wang JH, Tang HJ, Yu KW, Liu YC, Chuang YC, Liu CE, Hsueh PR.

Int J Antimicrob Agents. 2012 Jun;40 Suppl:S29-36. doi: 10.1016/S0924-8579(12)70007-9.

PMID:
22749056
3.

Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010.

Huang CC, Chen YS, Toh HS, Lee YL, Liu YM, Ho CM, Lu PL, Liu CE, Chen YH, Wang JH, Tang HJ, Yu KW, Liu YC, Chuang YC, Xu Y, Ni Y, Ko WC, Hsueh PR.

Int J Antimicrob Agents. 2012 Jun;40 Suppl:S4-10. doi: 10.1016/S0924-8579(12)70003-1.

PMID:
22749058
4.

In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.

Fraenkel CJ, Ullberg M, Bernander S, Ericson E, Larsson P, Rydberg J, Törnqvist E, Melhus A.

Scand J Infect Dis. 2006;38(10):853-9.

PMID:
17008228
6.

Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.

Valenza G, Seifert H, Decker-Burgard S, Laeuffer J, Morrissey I, Mutters R; COMPACT Germany Study Group.

Int J Antimicrob Agents. 2012 Mar;39(3):255-8. doi: 10.1016/j.ijantimicag.2011.10.015. Epub 2012 Jan 9.

PMID:
22230334
7.

[Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes].

Baquero F, Cercenado E, Cisterna R, de la Rosa M, García-Rodríguez JA, Gobernado M, Pérez JL, Manchado P, Martín R, Pascual A, Picazo J, Prats G, Rubio C, Snyder TA, Sanz-Rodríguez C.

Rev Esp Quimioter. 2006 Mar;19(1):51-9. Spanish.

8.

The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.

Trivedi M, Patel V, Soman R, Rodriguez C, Singhal T.

J Assoc Physicians India. 2012 Aug;60:28-30. Erratum in: J Assoc Physicians India. 2012 Dec;60:20. J Assoc Physicians India. 2012 Sep;60:54. Trivedi, Mayur [corrected to Trivedi, Mayuri].

PMID:
23405518
9.
10.

Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.

Jean SS, Lee WS, Bai KJ, Yu KW, Hsu CW, Yu KW, Liao CH, Chang FY, Ko WC, Wu JJ, Chen YH, Chen YS, Liu JW, Lu MC, Liu CY, Chen RJ, Hsueh PR.

Diagn Microbiol Infect Dis. 2015 Apr;81(4):290-5. doi: 10.1016/j.diagmicrobio.2014.09.027. Epub 2014 Oct 5.

PMID:
25600841
11.

Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.

Toh HS, Chuang YC, Huang CC, Lee YL, Liu YM, Ho CM, Lu PL, Liu CE, Chen YH, Wang JH, Ko WC, Yu KW, Liu YC, Chen YS, Tang HJ, Hsueh PR.

Int J Antimicrob Agents. 2012 Jun;40 Suppl:S18-23. doi: 10.1016/S0924-8579(12)70005-5.

PMID:
22749054
12.

Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011).

Biedenbach DJ, Bouchillon SK, Hoban DJ, Hackel M, Phuong DM, Nga TT, Phuong NT, Phuong TT, Badal RE.

Diagn Microbiol Infect Dis. 2014 Aug;79(4):463-7. doi: 10.1016/j.diagmicrobio.2014.05.009. Epub 2014 May 17.

PMID:
24923210
13.

Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.

Patel N, Harrington S, Dihmess A, Woo B, Masoud R, Martis P, Fiorenza M, Graffunder E, Evans A, McNutt LA, Lodise TP.

J Antimicrob Chemother. 2011 Jul;66(7):1600-8. doi: 10.1093/jac/dkr156. Epub 2011 Apr 19.

PMID:
21508008
14.

Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007.

Hoban DJ, Bouchillon SK, Hawser SP, Badal RE.

Diagn Microbiol Infect Dis. 2010 Jan;66(1):78-86. doi: 10.1016/j.diagmicrobio.2009.06.009. Epub 2009 Sep 5.

PMID:
19733993
15.

Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.

Zhang R, Cai JC, Zhou HW, Nasu M, Chen GX.

J Med Microbiol. 2011 Dec;60(Pt 12):1813-9. doi: 10.1099/jmm.0.025668-0. Epub 2011 Aug 11.

PMID:
21835972
16.

Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence.

Nicolau DP, Carmeli Y, Crank CW, Goff DA, Graber CJ, Lima AL, Goldstein EJ.

Int J Antimicrob Agents. 2012 Jan;39(1):11-5. doi: 10.1016/j.ijantimicag.2011.08.018. Epub 2011 Nov 1. Review.

PMID:
22047702
17.

Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints.

Brink AJ, Botha RF, Poswa X, Senekal M, Badal RE, Grolman DC, Richards GA, Feldman C, Boffard KD, Veller M, Joubert I, Pretorius J.

Surg Infect (Larchmt). 2012 Feb;13(1):43-9. doi: 10.1089/sur.2011.074. Epub 2012 Jan 5.

PMID:
22220506
18.

Comparative review of the carbapenems.

Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA.

Drugs. 2007;67(7):1027-52. Review.

PMID:
17488146
19.
20.

Supplemental Content

Support Center